Caudill Cortney sold HALO
March 9, 2026 · Form 4 insider transaction
Caudill Cortney sold 17,900 shares of Halozyme Therapeutics, Inc. at $67.75 per share, a transaction worth $1.21M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
17,900
Price
$67.75
Total value
$1.21M
InsiderCaudill Cortney
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 9, 2026
Filing dateMarch 10, 2026
Shares owned after16,466
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a weighted average sales price per share. The shares were sold at prices ranging from $67.210 to $68.195. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.